Furthermore, the expression in BRCA, KIRC, KIRP, LIHC, LUAD, LUSC, and UCEC was higher in late-stage cancers compared to early stages, representing a possible role of UBE2C in cancer progression and invasion (Figure 2, cancer without and/or small numbers of normal matches (when there is only one sample in each stage) were excluded from this analysis). Here, UBE2C is linked to cancer.